Search

Your search keyword '"Flores, Eva Iglesias"' showing total 18 results

Search Constraints

Start Over You searched for: Author "Flores, Eva Iglesias" Remove constraint Author: "Flores, Eva Iglesias"
18 results on '"Flores, Eva Iglesias"'

Search Results

2. Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study.

3. Mo1860 REAL-WORLD LONG-TERM EFFECTIVENESS OF USTEKINUMAB IN CROHN'S DISEASE: RESULTS FROM THE ENEIDA REGISTRY

4. Su1865 – Real-World Short-Term Effectivenes of Ustekinumab in Crohn’s Disease: Results from the Eneida Registry

5. Tu1996 Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicenter Study

6. Mo1831 Evolution of the Incidence of Inflamatory Bowel Disease in the South of Spain in Two Periods

7. Sa1260 Durability of the anti-HBs Titers After Vaccination Against Hepatitis B Virus (HBV) in Patients With Inflammatory Bowel Disease (IBD)

8. Tu1107 Adalimumab Dose Escalation Is Effective for Managing Loss of Response in Ulcerative Colitis

9. Sa1267 Prospective, Randomized Clincal Trial Comparing the Efficacy of Two Vaccines Against Hepatis B Virus (HBV) in Inflamatory Bowel Disease (IBD) Patients

10. Tu1291 Infliximab Serum Levels Do Not Predict Remission After the Induction Phase in Crohn's Disease Patients

11. Mo1740 Prospective, Randomized Clinical Trial Comparing the Efficacy of Two Vaccines Against Hepatitis B Virus (HBV) in Inflammatory Bowel Disease (IBD) Patients

12. Mo1257 Outcomes of Surgical Treatment of Entero-Urinary Fistulas in Crohn's Disease

13. 951 Effectiveness of Anti-TNF Agents in the Treatment of Entero-Urinary Fistulas in Crohn's Disease

14. Mo1383 Entero-Urinary Fistulas in Crohn's Disease: Prevalence and Clinical Manifestations

15. Sa1933 Safety of Immunomodulators and Anti-TNF Drugs for the Treatment of Inflammatory Bowel Disease (IBD) During Pregnancy

16. W1274 Efficacy and Safety of Infliximab Rescue Therapy After Cyclosporine Failure in Patients With Steroid-Refractory Ulcerative Colitis: A Multicenter Study

17. Infliximab Serum Levels Do Not Predict Remission After the Induction Phase in Crohn's Disease Patients

18. REAL-WORLD SHORT-TERM EFFECTIVENES OF USTEKINUMAB IN CROHN'S DISEASE: RESULTS FROM THE ENEIDA REGISTRY

Catalog

Books, media, physical & digital resources